Redeye provides a research update following the Q3 report recently published by Coegin Pharma.
Redeye provides a short research update following the outcome of the TO3 warrants recently published by Coegin Pharma.
Redeye leaves a note following Coegin’s recent announcements of a signed Joint Development Agreement (JDA) with an established cosmetics com...
Redeye provides a research update following the Q2 report recently published by Coegin Pharma.
Redeye leaves a comment on Coegin Pharma’s announcement of having secured an exclusive agreement with the University of Bradford to acquire ...
Redeye initiates coverage of Coegin Pharma, a hub and spoke biotech company with a diverse array of potential revenue streams.
